Amicus Therapeutics (FOLD) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Get Alerts FOLD Hot Sheet
Price: $14.49 --0%
Financial Fact:
Research and development: 32.46M
Today's EPS Names:
CGEH, NAKA, APOG, More
Financial Fact:
Research and development: 32.46M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Amicus Therapeutics (NASDAQ: FOLD) reported Q2 EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $80.7 million versus the consensus estimate of $85.87 million.
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Kite Realty sells City Center in White Plains for $50 million
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
